5例宫颈混合性腺癌-神经内分泌癌临床病理特征分析
作者: |
1王桃丽,
1杨珍玉,
1陈栋良
1 株洲市中心医院病理科,湖南 株洲 412007 |
通讯: |
陈栋良
Email: 314247278@qq.com |
DOI: | 10.3978/j.issn.2095-6959.2020.03.038 |
摘要
分析5例宫颈混合性腺癌-神经内分泌癌患者的临床特点、病理形态和免疫表型。5例患者发病年龄38~82(平均54)岁,因不规则阴道出血或接触性出血入院。病理形态均表现为小细胞癌合并有多少不等的腺癌成分。免疫组织化学染色结果显示:5例小细胞癌区均表达广谱细胞角蛋白(cytokeratin pan,CK-P)、突触素(synaptophysin,Syn)、神经细胞黏附分子56(neuronal cell adhesion molecule,CD56),2例表达嗜铬素蛋白(chromogranin,CgA),2例表达甲状腺转录因子1(thyroid transcription factor-1,TTF-l)。5例腺癌区均表达CK-P、癌胚抗原(carcinoembryonic antigen,CEA),神经内分泌标志Syn,CgA,CD56均阴性。5例患者治疗后随访3~36个月,其中3例死亡,2例存活。宫颈混合性腺癌-神经内分泌癌是罕见的宫颈恶性肿瘤,预后差。确诊需要结合组织形态学和免疫组织化学标志。
关键词:
宫颈;混合性腺癌-神经内分泌癌;小细胞癌;诊断;预后
Clinicopathological analysis of 5 cases of cervical mixed adenocarcinoma and neuroendocrine carcinoma
CorrespondingAuthor: CHEN Dongliang Email: 314247278@qq.com
DOI: 10.3978/j.issn.2095-6959.2020.03.038
Abstract
The clinical characteristics, pathological morphology and immunophenotype of 5 cases of cervical mixed adenocarcinoma-neuroendocrine carcinoma were analyzed. The onset age of 5 patients was 38–82 years old, with an average age of 54 years old, and they were admitted due to irregular vaginal bleeding or contact bleeding. Pathologic morphology showed small cell carcinoma with various adenocarcinoma components. Immunohistochemical staining showed that 5 of the 5 patients expressed broad-spectrum cytokeratin pan (CK-P), synaptophysin (Syn), nerve cell adhesion molecule 56 (CD56), and 2 expressed chromogranin (CgA), 2 cases expressed thyroid transcription factor 1 (TTF-l). CK-P, carcinoembryonic antigen (CEA) and neuroendocrine markers Syn, CgA and CD56 were all positive in 5 cases of adenocarcinoma. Five patients were followed up for 3 to 36 months after treatment, of which 3 died and 2 survived. Mixed adenocarcinoma of cervix-neuroendocrine carcinoma is a rare cervical malignant tumor with poor prognosis. Diagnosis needs to be combined with histological morphology and immunohistochemical markers.
Keywords:
cervix; mixed adenocarcinoma-neuroendocrine carcinoma; small cell carcinoma; diagnosis; prognosis